Evidence map›Paper›PMID 28875388›Full record

Trial reportMolecular and cellular biochemistry2018

Intrinsic renal cells induce lymphocytosis of Th22 cells from IgA nephropathy patients through B7-CTLA-4 and CCL-CCR pathways.

Lu Gan, Qiaoling Zhou, Xiaozhao Li, Chen Chen, Ting Meng, Jiaxi Pu, Mengyuan Zhu, Chenggen Xiao

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Molecular and cellular biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. CCR1Journal of advanced research · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Article
  16. Article
  17. American journal of translational research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lu GanDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China. 543523915@qq.com.
Qiaoling ZhouDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xiaozhao LiDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Chen ChenDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Ting MengDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jiaxi PuDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Mengyuan ZhuDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Chenggen XiaoDepartment of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xiangya Hospital Central South University · CNCentral South University · CN

Funding

National Natural Science Foundation of China 81270786National Natural Science Foundation of China 81470933
6 · The paper itself

Abstract

IgA nephropathy (IgAN), the most common glomerulonephritis, has an unclear pathogenesis. The role of Th22 cells, which are intimately related to proteinuria and progression in IgAN, in mediating infection-related IgAN is unclear. This study aimed to characterize the association between intrinsic renal cells (tubular epithelial cells and mesangial cells) and Th22 cells in immune regulation of infection-related IgAN and to elucidate the impact of Th22 lymphocytosis; the proinflammatory cytokines IL-1, IL-6, and TNF-α; and CCL chemokines on kidney fibrosis. Hemolytic streptococcus infection induced an increase in IL-1, IL-6, and TNF-α, resulting in Th22 cell differentiation from T lymphocytes obtained from patients with IgAN, and the CCL20-CCR6, CCL22-CCR4, and/or CCL27-CCR10 axes facilitated Th22 cell chemotaxis. The increased amount of Th22 cells caused an increase in TGF-β1 levels, and anti-CD80, anti-CD86, and CTLA-4Ig treatment reduced TGF-β1 levels by inhibiting Th22 lymphocytosis and secretion of cytokines and chemokines, thus potentially relieving kidney fibrosis. Our data suggest that Th22 cells might be recruited into the kidneys via the CCL20-CCR6, CCL22-CCR4, and/or CCL27-CCR10 axes by mesangial cells and tubular epithelial cells in infection-related IgAN. Th22 cell overrepresentation was attributed to stimulation of the B7-CTLA-4Ig antigen-presenting pathway and IL-1, IL-6, and TNF-α.

Indexed as

AdolescentAdultB7-1 AntigenChemokine CCL1CTLA-4 AntigenFemaleGlomerulonephritis, IGAHumansLymphocytosisMaleMiddle AgedReceptors, CCRSignal TransductionT-Lymphocytes, Helper-InducerB7-1 AntigenChemokine CCL1CTLA-4 AntigenCTLA4 protein, humanReceptors, CCRAntigen presentationC–C chemokinesChemotaxisIgA nephropathyInflammatory cytokinesTh22 cells

Identifiers

PMID28875388
OpenAlexW2750762266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.